University of Liverpool researchers, working with F2G Limited (Eccles, Manchester), have developed a new antifungal drug to help in the treatment of life threatening invasive fungal infections such as invasive aspergillosis.
Invasive fungal infections are common and often lethal. Despite optimal medical care mortality is 20-30% at six weeks and dramatically rises to 80-100% for drug resistant infection.
These infections occur most commonly in the context of leukemia and bone marrow transplantation and often in young patients with otherwise curable disease.
The researchers, led by Professor William Hope from the University’s Antimicrobial Pharmacodynamics and Therapeutics (APT) Group, have characterised the biochemical and physiologic effects (pharmacodynamics) of F901318, which is the lead compound of the new class of drugs termed the ‘orotomides’.
The ‘orotomides’, discovered by F2G Limited, have a novel mechanism of action which is the specific biochemical interaction through which a drug substance produces its pharmacological effect.
This is the first new class of antifungal agent to be discovered in the last three decades.
The study, which was supported by a research grant by F2G, has been published in mBio.
APT’s work provides the underpinning evidence for efficacy and dosage justification for the very first patients receiving the new drug. Such information is required by regulatory agencies such as the European Medicines Agency and the Food and Drug Administration before clinical studies can proceed.
Professor Hope, said: “Antifungal resistance represents a major global clinical challenge. This study provides the necessary information to enable F901318 to be developed for clinical use.”
Learn more: Researchers help develop new antifungal drug
The Latest on: Antifungal drug
- Laviterbi 250mg Tableton April 17, 2021 at 5:39 am
Laviterbi 250mg Tablet is used in the treatment of Fungal infections. View Laviterbi 250mg Tablet (strip of 7 tablets) uses, composition, side-effects, price, substitutes, drug interactions, ...
- Anti Fungal 2021, Focuses on Top Companies, Global Industry Analysis, Recent Trendson April 14, 2021 at 11:03 pm
The global Anti Fungal Drugs Market size is likely to reach USD 13.17 billion by 2027 on account of the increasing prevalence of skin infections ...
- Superbug killer: New nanotech destroys bacteria and fungal cellson April 13, 2021 at 7:51 am
Researchers have developed a new superbug-destroying coating that could be used on wound dressings and implants to prevent and treat potentially deadly bacterial and fungal infections.
- Covid treatment: Anti fungal drug shown to have impressive results in killing COVID-19on April 9, 2021 at 7:59 am
COVID treatment has been the centre of many studies with one pointing to the use of an anti fungal drug and its ability to reduce virus yield, potentially killing off the virus.
- Antifungal Agent Market Growth Prospects, Key Vendors, future to Scenario Forecast to 2025on April 8, 2021 at 7:03 am
Antifungal Agent market is a type of drug that detect and eliminate fungal infection from foreign body with minimal toxic side effects to the body. These infections may lead to death in patients with ...
- Alembic Pharma rises after USFDA approval for antifungal drugon April 8, 2021 at 12:01 am
Alembic Pharmaceuticals gained 1.1% to Rs 983.95 after the drug maker announced that its joint venture has received US drug regulator's tentative approval for efinaconazole topical solution.
- Antifungal and antidepressant drugs may help protect against COVID-19on April 7, 2021 at 1:21 am
New research published in the British Journal of Pharmacology indicates that two currently available medications—an antifungal drug and an antidepressant—can effectively inhibit the virus that causes ...
- Antifungal and antidepressant medicine may help protect against Covid-19on April 7, 2021 at 12:30 am
A new study has claimed that a common antidepressant and antifungal treatment could help treat Covid-19. New research published in the British Journal of Pharmacology has shown that the antifungal ...
- Antifungal and Antidepressants may Save from COVID-19on April 6, 2021 at 11:33 pm
Two currently available medications--an antifungal drug and an antidepressant--can effectively inhibit the virus that causes COVID-19 in laboratory cells.
- Antifungal and antidepressant drugs can effectively inhibit COVID-19 viruson April 6, 2021 at 11:08 pm
New research published in the British Journal of Pharmacology indicates that two currently available medications--an antifungal drug and an antidepressant--can effectively inhibit the virus that ...
via Google News and Bing News